Podlipodcast player Webplayer

Decera Clinical Education Oncology Podcast

Decera Clinical Education Oncology Podcast

TROP2-Directed Antibody–Drug Conjugates in Non-Small-Cell Lung Cancer: Current Use in Clinical Practice and Future Directions

Decera Clinical Education Oncology Podcast · Apr 13, 2026 · 33:13

0:0033:13

Listen in the Podli app 🎧

Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.

In this episode, Dr Matthew Gubens and Dr Helena Yu discuss the evolving role of TROP2-directed therapies in non-small-cell lung cancer, with a focus on how antibody–drug conjugates (ADCs) fit into current treatment strategies, including

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Oncology Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters:

Matthew Gubens, MD, MS, FASCO​
Medical Director, Thoracic Medical Oncology​
University of California, San Francisco​
San Francisco, California

Helena Yu, MD​
Professor of Medicine​
Thoracic Oncology Service​
Memorial Sloan Kettering Cancer Center​
New York, New York

Link to full program:
https://bit.ly/41vAnfH


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episodes: Decera Clinical Education Oncology Podcast

PodliGet the free Podli app
↓ App